ClinConnect ClinConnect Logo
Search / Trial NCT06417177

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · May 13, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how aging and menopause affect the body's response to low oxygen levels, particularly how blood vessels widen in women of different ages. Researchers want to understand how certain receptors in the body play a role in this process. The study is specifically focusing on women who are premenopausal, perimenopausal, or postmenopausal, and it aims to recruit participants between the ages of 25 and 66.

To be eligible for this study, women must be healthy and have a body weight that falls within a normal range. However, women who are pregnant, breastfeeding, or have certain health conditions such as diabetes or high blood pressure will not be able to participate. If you join the study, you can expect to undergo various tests to help researchers gather information about your body's response to low oxygen. This trial is important because it could provide insights into how menopause and aging affect women's health, particularly related to heart and blood vessel function.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female assigned at birth
  • Pre, peri- or post-menopausal
  • Healthy weight (BMI ≥18 and ≤30 kg/m2)
  • Exclusion Criteria:
  • Male (assigned at birth)
  • Pregnancy, breastfeeding
  • Use of hormone replacement therapies
  • Hysterectomy
  • Body mass index \>30 kg/m2
  • Diagnosed sleep apnea
  • Current smoking/Nicotine/Drug use
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Blood pressure ≥140/90 mmHg
  • Diabetes, Polycystic ovarian syndrome
  • Communication barriers
  • Prescription medications
  • Malignant cancer

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported